Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFenner PLC Regulatory News (FENR)

  • There is currently no data for FENR

Trading Update

7 Jul 2017 07:00

RNS Number : 3743K
Fenner PLC
07 July 2017
 

7 July 2017

Fenner PLC("Fenner" or "the Group")

Trading update

Fenner is providing its customary trading update covering the period from 1 March to 7 July 2017.

The Group has continued to make strong progress, principally in new product development, augmented by a further increase in the US rig count.

Business review

AEP's performance has continued to strengthen across each product area. In particular, our Medical businesses are experiencing strong revenue growth from the development of new customer projects. This provides an encouraging platform for long term growth in line with our plans. In Oil & Gas, the growing order book is now translating into increased sales. Our Industrial businesses are performing ahead of last year, reflecting new product launches.

ECS continues to deliver the planned improvements.

Financing review

Cash flow during the period has remained in line with expectations.

On 1 June, US$90 million of 5.78% Senior Guaranteed Loan Notes matured and, as planned, were repaid at par out of the Group's cash deposits. This will reduce the ongoing interest charge accordingly.

Outlook

Trading across the Group remains positive and, on the basis of the improved outlook, most notably in the medical businesses, the Board anticipates that the Group's operating profit for the financial year ending 31 August 2017 will be comfortably ahead of its previous expectations, with the added benefit of a reduced interest charge going forward.

Financial calendar

The Group expects to release its results for its financial year ending 31 August 2017 on 15 November 2017.

 

For further information please contact:

Fenner PLC

01482 626501

Mark Abrahams, Chief Executive Officer

John Pratt, Group Finance Director

 

Weber Shandwick Financial

020 7067 0700

Nick Oborne / Tom Jenkins

Notes to editors:

Fenner PLC is a world leader in reinforced polymer technology, providing local engineered solutions for performance-critical applications. The Group operates through two divisions:

Advanced Engineered Products: The AEP division is a group of nine businesses that use advanced polymeric materials and technical expertise to provide high value-added solutions to customers' most challenging engineering problems across a variety of markets, generally classified as specialist industrial, medical and oil & gas. AEP's trading names include Hallite, Fenner Precision, Fenner Drives, Secant Group, Charter Medical, CDI Energy Products and EGC Critical Components.

Engineered Conveyor Solutions: The ECS division, trading under the Fenner Dunlop, Fenner and Dunlop brand names, is an established global leader in the supply of heavyweight conveyor belting and related services to the mining, industrial and bulk materials markets. ECS has leading presences in the Northern Hemisphere (principally North America and Europe) and the Southern Hemisphere (principally Australia).

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFFEDSIRIID
Date   Source Headline
2nd Mar 20129:20 amRNSHolding(s) in Company
1st Mar 20122:45 pmRNSBlocklisting Interim Review
24th Feb 201211:21 amRNSDirector/PDMR Shareholding
17th Feb 20124:18 pmRNSHolding(s) in Company
16th Feb 20124:19 pmRNSHolding(s) in Company
1st Feb 20123:57 pmRNSDirector/PDMR Shareholding
19th Jan 20123:07 pmRNSResult of AGM
16th Jan 20123:18 pmRNSHolding(s) in Company
11th Jan 20127:00 amRNSAGM and IMS
9th Jan 20122:44 pmRNSHolding(s) in Company
4th Jan 201211:32 amRNSAnnual Information Update
8th Dec 20112:10 pmRNSDocuments available for Inspection/Notice of AGM
6th Dec 201111:41 amRNSHolding(s) in Company
1st Dec 20117:00 amRNSAcquisition
30th Nov 201110:41 amRNSTotal Voting Rights
24th Nov 20113:41 pmRNSDirector/PDMR Shareholding
22nd Nov 201110:21 amRNSDirector/PDMR Shareholding
21st Nov 20114:34 pmRNSHolding(s) in Company
18th Nov 201110:41 amRNSDirector/PDMR Shareholding
15th Nov 201110:22 amRNSAdditional Listing
9th Nov 20117:00 amRNSFinal Results
26th Sep 20111:37 pmRNSHolding(s) in Company
19th Sep 20111:12 pmRNSDirector Declaration
6th Sep 20117:00 amRNSPre-Close Trading Update
2nd Sep 20119:23 amRNSBlocklisting Interim Review
1st Sep 20117:00 amRNSCompletion of Acquisition
24th Aug 201112:33 pmRNSHolding(s) in Company
23rd Aug 20117:00 amRNSAcquisition
4th Aug 20113:38 pmRNSDirector/PDMR Shareholding
18th Jul 20117:00 amRNSInterim Management Statement
4th Jul 20117:00 amRNSAcquisition
8th Jun 201111:37 amRNSDirector/PDMR Shareholding
31st May 20119:45 amRNSTotal Voting Rights
27th May 20112:23 pmRNSUS$200 million Private Placement
4th May 20117:00 amRNSAdditional Listing
28th Apr 201111:30 amRNSAcquisition
27th Apr 20117:00 amRNSHalf Year Results
13th Apr 20113:29 pmRNSHolding(s) in Company
7th Mar 20117:00 amRNSPre-Close Trading Update
2nd Mar 20113:15 pmRNSRe Board Changes
1st Mar 201111:35 amRNSBlocklisting Interim Review
28th Feb 20119:32 amRNSTotal Voting Rights
24th Feb 20112:01 pmRNSDirector/PDMR Shareholding
24th Feb 20111:53 pmRNSDirector/PDMR Shareholding
17th Feb 20114:35 pmRNSPDMR Shareholding PSP
9th Feb 201110:14 amRNSAdditional Listing
28th Jan 201110:00 amRNSHolding(s) in Company
14th Jan 20112:05 pmRNSResult of AGM
12th Jan 20117:00 amRNSAGM and IMS
10th Jan 20112:31 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.